Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 2
1980 1
1981 1
1982 2
1983 2
1984 4
1986 4
1988 1
1989 4
1990 1
1992 3
1994 2
1995 2
1997 1
1998 3
1999 6
2000 5
2001 4
2002 6
2003 8
2004 6
2005 9
2006 5
2007 11
2008 6
2009 13
2010 8
2011 11
2012 16
2013 25
2014 29
2015 30
2016 26
2017 30
2018 29
2019 22
2020 22
Text availability
Article attribute
Article type
Publication date

Search Results

310 results
Results by year
Filters applied: . Clear all
Page 1
Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis.
Hu CL, Nydes M, Shanley KL, Morales Pantoja IE, Howard TA, Bizzozero OA. Hu CL, et al. J Neurochem. 2019 Feb;148(3):426-439. doi: 10.1111/jnc.14604. Epub 2018 Dec 3. J Neurochem. 2019. PMID: 30289974 Free PMC article.
In this study, we investigate whether GPx4 expression is altered in multiple sclerosis and its animal model experimental autoimmune encephalomyelitis (EAE). The results clearly show that mRNA expression for all three GPx4 isoforms (cytoplasmic, mitochondrial and nuc …
In this study, we investigate whether GPx4 expression is altered in multiple sclerosis and its animal model experimental autoi …
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
Cruickshank TM, Reyes AR, Ziman MR. Cruickshank TM, et al. Medicine (Baltimore). 2015 Jan;94(4):e411. doi: 10.1097/MD.0000000000000411. Medicine (Baltimore). 2015. PMID: 25634170 Free PMC article. Review.
Strength training has, in recent years, been shown to be beneficial for people with Parkinson disease and multiple sclerosis. ...Strength training is useful for increasing muscle strength in Parkinson disease and to a lesser extent multiple sclerosis.. …
Strength training has, in recent years, been shown to be beneficial for people with Parkinson disease and multiple sclerosis. …
Glutathione in multiple sclerosis: more than just an antioxidant?
Carvalho AN, Lim JL, Nijland PG, Witte ME, Van Horssen J. Carvalho AN, et al. Mult Scler. 2014 Oct;20(11):1425-31. doi: 10.1177/1352458514533400. Epub 2014 May 19. Mult Scler. 2014. PMID: 24842957 Review.
Oxidative stress has been strongly implicated in both the inflammatory and neurodegenerative pathological mechanisms in multiple sclerosis (MS). ...Glutathione (GSH) is the major antioxidant in the brain, and as such plays a pivotal role in the detoxification …
Oxidative stress has been strongly implicated in both the inflammatory and neurodegenerative pathological mechanisms in multiple s
Glutathione in multiple sclerosis.
Ferreira B, Mendes F, Osório N, Caseiro A, Gabriel A, Valado A. Ferreira B, et al. Br J Biomed Sci. 2013;70(2):75-9. doi: 10.1080/09674845.2013.11669939. Br J Biomed Sci. 2013. PMID: 23888609 Review.
Multiple sclerosis is a chronic inflammatory disease of the central nervous system, characterised mainly as an autoimmune neurodegenerative disorder. ...Clarification of the mechanisms involved in oxidative stress, in different forms of multiple sclerosis
Multiple sclerosis is a chronic inflammatory disease of the central nervous system, characterised mainly as an autoimmune neur
Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.
Bhargava P, Fitzgerald KC, Calabresi PA, Mowry EM. Bhargava P, et al. JCI Insight. 2017 Oct 5;2(19):e95302. doi: 10.1172/jci.insight.95302. JCI Insight. 2017. PMID: 28978801 Free PMC article. Clinical Trial.
BACKGROUND: Our goal was to identify changes in the metabolome in multiple sclerosis (MS) and how vitamin D supplementation alters metabolic profiles in MS patients and healthy controls. ...FUNDING: This study was supported by NIH grant K23 NS067055, grants from the …
BACKGROUND: Our goal was to identify changes in the metabolome in multiple sclerosis (MS) and how vitamin D supplementation al …
Oxidative stress-related biomarkers in multiple sclerosis: a review.
Ibitoye R, Kemp K, Rice C, Hares K, Scolding N, Wilkins A. Ibitoye R, et al. Biomark Med. 2016 Aug;10(8):889-902. doi: 10.2217/bmm-2016-0097. Epub 2016 Jul 14. Biomark Med. 2016. PMID: 27416337 Free article. Review.
AIM: To provide an up-to-date review of oxidative stress biomarkers in multiple sclerosis and thus identify candidate molecules with greatest promise as biomarkers of diagnosis, disease activity or prognosis. ...RESULTS: Nitric oxide metabolites, superoxide dismutas …
AIM: To provide an up-to-date review of oxidative stress biomarkers in multiple sclerosis and thus identify candidate molecule …
Update on riboflavin and multiple sclerosis: a systematic review.
Naghashpour M, Jafarirad S, Amani R, Sarkaki A, Saedisomeolia A. Naghashpour M, et al. Iran J Basic Med Sci. 2017 Sep;20(9):958-966. doi: 10.22038/IJBMS.2017.9257. Iran J Basic Med Sci. 2017. PMID: 29085589 Free PMC article. Review.
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Riboflavin plays an important role in myelin formation, and its deficiency is implicated as a risk factor for multiple sclerosis. ...The vitamin addit
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Riboflavin plays an impo
Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
Islam MT. Islam MT. Neurol Res. 2017 Jan;39(1):73-82. doi: 10.1080/01616412.2016.1251711. Epub 2016 Nov 3. Neurol Res. 2017. PMID: 27809706 Review.
Oxidative stress has been considered to be linked to the etiology of many diseases, including neurodegenerative diseases (NDDs) such as Alzheimer diseases, Amyotrophic lateral sclerosis, Friedreich's ataxia, Huntington's disease, Multiple sclerosis, and Parki …
Oxidative stress has been considered to be linked to the etiology of many diseases, including neurodegenerative diseases (NDDs) such as Alzh …
Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ, Plemel JR, Assinck P, Manesh SB, Muir FGW, Hirata R, Berson M, Liu J, Wegner M, Emery B, Moore GRW, Tetzlaff W. Duncan GJ, et al. Acta Neuropathol. 2017 Sep;134(3):403-422. doi: 10.1007/s00401-017-1741-7. Epub 2017 Jun 19. Acta Neuropathol. 2017. PMID: 28631093
Remyelination is limited in the majority of multiple sclerosis (MS) lesions despite the presence of oligodendrocyte precursor cells (OPCs) in most lesions. ...OPC-specific Myrf deletion did not alter recruitment or proliferation of these cells after demyelination, b …
Remyelination is limited in the majority of multiple sclerosis (MS) lesions despite the presence of oligodendrocyte precursor …
[Multiple sclerosis: current immunological aspects].
Cuevas-García C. Cuevas-García C. Rev Alerg Mex. 2017 Jan-Mar;64(1):76-86. doi: 10.29262/ram.v64i1.253. Rev Alerg Mex. 2017. PMID: 28188715 Review. Spanish.
Multiple sclerosis is the most common inflammatory, chronic and degenerative condition of the central nervous system, and represents the first cause of disability in young adults. ...In this review, the immune reaction main components and neurodegeneration present i
Multiple sclerosis is the most common inflammatory, chronic and degenerative condition of the central nervous system, and repr
310 results
Jump to page
Feedback